Education
About Us
Working with TipRanks
Follow Us
Steris (STE)
NYSE:STE
Earnings Data
Report Date
May 20, 2026After Close (Confirmed)
Period Ending
2026 (Q4)Consensus EPS Forecast
2.86Last Year’s EPS
2.74Same Quarter Last Year
Moderate Buy
Based on 4 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presented solid top-line growth, EPS expansion, strong segment-level performance (notably AST capital equipment and healthcare services), and maintained full-year guidance — indicating operational resilience. However, meaningful margin pressure from tariffs and inflation, a notable gross margin decline, and seasonal/timing risks for the fourth quarter temper the outlook. Management is actively pursuing mitigation efforts and remains disciplined on capital and M&A. Overall, positives (revenue, EPS, segment momentum, backlog, leverage) outweigh the headwinds (tariffs, margin compression, near-term volatility).Company Guidance
Top-Line Growth
Total as-reported revenue grew 9% in the third quarter; constant currency organic revenue grew 8%, driven by volume and ~200 basis points of price.
Earnings and EPS Expansion
Adjusted net income from continuing operations was $249.4 million and adjusted diluted EPS was $2.53, a 9% increase year-over-year.
Segment Strength — AST Capital Equipment
AST constant currency organic revenue grew 8% with capital equipment revenue up 103% year-over-year; AST EBIT margin improved to 45.1% (up 30 basis points).
Service and Consumables Momentum
Healthcare services grew 11% in the quarter and consumables grew 8%; Life Sciences consumables grew 11% and Life Sciences constant currency organic revenue increased 5%.
Backlog and Capital Stability
Healthcare capital equipment backlog remained over $400 million and Life Sciences backlog held above $100 million, supporting future revenue visibility.
Maintained Full-Year Guidance
Company maintained fiscal 2026 outlook: ~8%–9% as-reported revenue growth, 7%–8% constant currency organic revenue growth, EPS range (noted as) approximately $10.00 to $10.30, free cash flow guidance $850 million, and CapEx guidance $375 million.
Balance Sheet and Leverage
Ended the quarter with $1.9 billion in total debt and gross debt to EBITDA of approximately 1.2x, implying modest leverage and capacity to pursue strategic actions.
Cash Flow and Capital Discipline
Company reported year-to-date capital expenditures of $278.8 million and depreciation & amortization of $363.1 million; management highlighted year-over-year free cash flow improvement driven by higher earnings and lower capital spending.
Operational Actions and Mitigation
Management is pursuing tariff mitigation (supplier shifts, negotiations, alternative sourcing), productivity improvements, and efficiency gains to offset cost pressures.
STE Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
STE Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 04, 2026 | $263.60 | $243.19 | -7.74% |
Nov 05, 2025 | $241.97 | $258.76 | +6.94% |
Aug 06, 2025 | $219.54 | $234.45 | +6.79% |
May 14, 2025 | $225.25 | $244.44 | +8.52% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Steris (STE) report earnings?
Steris (STE) is schdueled to report earning on May 20, 2026, After Close (Confirmed).
What is Steris (STE) earnings time?
Steris (STE) earnings time is at May 20, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is STE EPS forecast?
STE EPS forecast for the fiscal quarter 2026 (Q4) is 2.86.
